Rubric Capital Management LP Morphic Holding, Inc. Transaction History

Rubric Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$24.14 - $30.37 $4.81 Million - $6.05 Million	199,264 New	199,264 $5.33 Million
Q3 2021 Nov 12, 2021	SELL	$53.61 - $67.5 $16.3 Million - $20.5 Million	-304,410 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$45.13 - $64.99 $9.72 Million - $14 Million	215,363 Added 241.85%	304,410 $17.5 Million
Q1 2021 May 14, 2021	SELL	$29.77 - $84.85 $861,037 - $2.45 Million	-28,923 Reduced 24.52%	89,047 $5.64 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $371,608 - $500,353	14,482 Added 13.99%	117,970 $3.96 Million

Q3 2020 Nov 13, 2020	BUY	$22.51 - $30.11 $2.33 Million - $3.12 Million	103,488 New	103,488 $2.83 Million

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.